Cameco Shares Regain Ground on Strong Fundamentals

Cameco shares recover as strong 2025 financials offset sector volatility. Analysts maintain bullish price targets up to $202 ahead of key shareholder events.

After a period of decline, shares in uranium producer Cameco have rebounded to trade around the $109 mark. The mid-March pullback, which saw the stock drop 4.1% on March 20, was not driven by company-specific issues. Instead, it reflected a broader sector trend as investors took profits following a retreat in the spot uranium price from its strong early-2026 highs.

Financial Performance Provides a Foundation

The recovery coincides with the market digesting the company's recently filed annual report for 2025, submitted to the U.S. SEC with full audited financials and management commentary. The strength of Cameco's operational performance had already been signaled by its fourth-quarter results in February. The company reported earnings per share of $0.36, surpassing consensus estimates by seven cents. Revenue came in at $874.6 million, significantly ahead of the $782.1 million analysts had forecast.

Looking ahead, Cameco has guided for uranium deliveries of 29 to 32 million pounds in 2026, a modest reduction from the 33 million pounds delivered the previous year. This anticipated volume adjustment had weighed on investor sentiment prior to the March sell-off.

Sustained Analyst Confidence Amid Volatility

Despite recent price swings, analyst sentiment toward Cameco remains overwhelmingly positive. Of the firms covering the stock, thirteen currently rate it a 'buy,' with only two advising investors to 'hold.' Price targets showcase considerable optimism, ranging from Goldman Sachs's $131 target (set in February 2026) to a high of $202 from the Canadian Imperial Bank of Commerce, which raised its target substantially in early March. Other notable revisions include GLJ Research lifting its target to $171.20 and RBC Capital Markets setting a $160 target in February.

Even with the stock trading approximately 24% below its twelve-month high of $135.24, this discount does not appear to concern market experts.

Key Upcoming Events for Shareholders

Investors are now looking to several imminent corporate events. Cameco is scheduled to release its proxy statement on April 2, 2026, in preparation for the Annual Meeting of Shareholders on May 7, 2026. Shareholders of record as of March 9, 2026, will be eligible to vote. Concurrently, the company will publish its Modern Slavery Report in compliance with Canadian legislation. The annual meeting is also expected to provide management with a platform to offer further details on its 2026 delivery strategy and its medium-term positioning within the global uranium market.